Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas (Q38395821)

2 September 2017

title

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas (English)

1 reference

2 September 2017

0 references

1 reference

1 reference

3

1 reference

2 September 2017

Ching-Hung Lin

7

0 references

Ann-Lii Cheng

object named as

Ann-Lii Cheng

8

0 references

author name string

Pei-Fang Wu

1

1 reference

2 September 2017

Wen-Chang Huang

2

1 reference

2 September 2017

Yen-Shen Lu

4

1 reference

2 September 2017

Jin-Yuan Shih

5

1 reference

2 September 2017

Shang-Gin Wu

6

1 reference

2 September 2017

publication date

2 July 2013

1 reference

Journal of Neuro-Oncology

2 September 2017

published in

1 reference

2 September 2017

volume

115

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

61-70

1 reference

A randomized trial of surgery in the treatment of single metastases to the brain.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

IGF-IR in neuroprotection and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Genetic variation in insulin-like growth factors and brain tumor risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1194-3

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

21 January 2018

1 reference

12 December 2020

Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival

1 reference

12 December 2020

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus

1 reference

12 December 2020

Characterization of insulin-like growth factor 1 in human primary brain tumors

1 reference

12 December 2020

Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.

1 reference

12 December 2020

A note on quantifying follow-up in studies of failure time

1 reference

12 December 2020

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation

1 reference

12 December 2020

Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib

1 reference

12 December 2020

Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers

1 reference

12 December 2020

Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response

1 reference

12 December 2020

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling

1 reference

12 December 2020

10.1007/S11060-013-1194-3

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1021161677

0 references

1 reference